Details for Patent: 11,359,203
Which drugs does patent 11,359,203 protect, and when does it expire?
Patent 11,359,203 protects RIVFLOZA and is included in one NDA.
This patent has nineteen patent family members in eleven countries.
Summary for Patent: 11,359,203
| Title: | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
| Abstract: | This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents. |
| Inventor(s): | Bob D. Brown, Henryk T. Dudek, Cheng Lai |
| Assignee: | Novo Nordisk Health Care AG |
| Application Number: | US16/918,239 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,359,203
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-001 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Start Trial | ||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-002 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Start Trial | ||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-003 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,359,203
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015330670 | ⤷ Start Trial | |||
| Australia | 2021286295 | ⤷ Start Trial | |||
| Canada | 2964168 | ⤷ Start Trial | |||
| China | 107257858 | ⤷ Start Trial | |||
| Denmark | 3204497 | ⤷ Start Trial | |||
| European Patent Office | 3204497 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
